Buprenorphine

Trade Name: 
BuTrans
Manufacturer/Distributor: 
Purdue Pharma
www.purdue.ca
Classification: 
Opioid analgesic
ATC Class: 
N02AE01 - Buprenorphine
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2010/02/05
Date Marketed in Canada (yyyy/mm/dd): 
2010/03/05
Presentation: 
Transdermal patch: 5 mg; DIN: 02341174. Delivers 5 mcg/hour.
Transdermal patch: 10 mg; DIN: 02341212. Delivers 10 mcg/hour.
Transdermal patch: 20 mg; DIN: 02341220. Delivers 20 mcg/hour.
Comments: 
Each patch delivers medication for seven days. It is indicated for the management of persistent pain of moderate intensity in adults who require continuous opioid analgesia for an extended period of time.